怡达股份(300721) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was ¥332,208,223.13, a decrease of 17.18% compared to ¥401,113,424.53 in the same period last year[5] - The net loss attributable to shareholders was ¥36,205,500.36, representing a decline of 835.16% from a profit of ¥4,924,877.86 in the previous year[5] - The net cash flow from operating activities was negative at ¥48,764,684.34, a significant drop of 548.62% from ¥10,869,982.27 in the prior year[5] - The company reported a net loss for the quarter, with total other income decreasing to CNY 1,767,222.85 from CNY 2,574,241.46[20] - The company reported a net loss of ¥42,979,986.46 for the current period, compared to a net profit of ¥878,490.21 in the previous period[21] - Operating profit decreased significantly to -¥56,246,979.46 from ¥1,882,056.20 year-over-year[21] - Total revenue from operating activities was ¥350,639,263.32, down from ¥420,463,391.53 in the previous period, representing a decline of approximately 16.6%[23] - The total comprehensive income attributable to the parent company was -¥36,205,500.36, compared to ¥4,924,877.86 in the previous period[22] Asset and Liability Management - The company's total assets decreased by 4.03% to ¥2,528,104,944.43 from ¥2,634,363,081.76 at the end of the previous year[5] - Total liabilities decreased to CNY 1,333,054,898.04 from CNY 1,398,546,275.46, a reduction of 4.7%[19] - The company's equity attributable to shareholders decreased to CNY 1,183,935,361.37 from CNY 1,217,953,134.51, a decline of 2.8%[19] Cash Flow Analysis - The net cash flow from financing activities increased dramatically by 10,506.66% to ¥21,556,761.44, primarily due to an increase in bank borrowings[9] - Cash inflow from financing activities was ¥294,612,300.00, down from ¥341,062,238.20 in the previous period[24] - The company experienced a net cash outflow from investing activities of -¥30,456,275.52, compared to -¥31,276,537.48 in the previous period[24] - Cash and cash equivalents at the end of the period stood at ¥130,466,647.37, a decrease from ¥132,323,711.39 at the end of the previous period[24] Shareholder Information - Total number of common shareholders at the end of the reporting period is 19,787[12] - Liu Zhun holds 20.80% of shares, totaling 34,295,684 shares, with 25,721,763 shares under lock-up[12] - Shen Guixiu holds 12.28% of shares, totaling 20,235,980 shares, with no shares under lock-up[12] - Liu Zhaoxuan holds 6.01% of shares, totaling 9,908,500 shares, with no shares under lock-up[12] - The top 10 shareholders collectively hold significant stakes, with Liu Zhun, Shen Guixiu, and Liu Zhaoxuan being the largest[12] - The company has a total of 25,721,763 shares under lock-up for Liu Zhun, which are subject to transfer restrictions[14] - The company has established a consensus action agreement among major shareholders, including Liu Zhun and Shen Guixiu, effective from November 16, 2024[12] - The company has a total of 1,204,600 shares under lock-up for Cai Guoqing, with a release date set for December 18, 2024[14] - The company has not reported any changes in the number of shares lent or returned through margin trading among the top shareholders[12] - The company’s management has a significant number of shares under lock-up, ensuring stability in shareholding structure[14] Operational Efficiency - Management expenses were reduced by 62.07% to ¥12,761,684.15 from ¥33,647,274.32 year-on-year[8] - The company experienced a 3088.59% decline in operating profit, resulting in a loss of ¥56,246,979.46 compared to a profit of ¥1,882,056.20 in the previous year[8] - Total operating costs amounted to CNY 383,502,041.89, down 4.5% from CNY 402,424,549.94 in the prior period[20] - Research and development expenses for the quarter were CNY 4,526,443.13, slightly up from CNY 4,186,789.31 in the previous period[20] Impairment Losses - The company reported a significant increase in asset impairment losses, which rose by 767.72% to ¥6,500,483.35 compared to the previous year[8] - The company incurred a credit impairment loss of ¥234,727.22, while asset impairment losses totaled ¥6,500,483.35[21] Return on Investment - The weighted average return on net assets was -2.96%, down from 0.40% in the same period last year[5] - The company recorded a basic and diluted earnings per share of -¥0.2196, compared to ¥0.0302 in the previous period[22]